ALGALAMO GROUP INC.Small cap · $1.97B · FY ending 2025-12-31
$162.24+0.47% · 2026-07-13 · EOD
59/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality47
narrow moat · ROIC 10%Value77
P/E 18.9 · 18% of 12-mo rangeMomentum41
death · price below 200-daySmart Money70
buying · 0 funds · 2P/2S insidersMixed trendDeath crossBelow 200-day
vs S&P 500-21.7%
6-mo excess Trailing performance1M +7.5%
3M -8.3%
6M -13.0%
YTD -4.8%
1Y -28.4%
P/E vs its last 12 months (our price history): 17.1 low → 27.1 high
Current price sits at the 18th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Narrow moat — ROIC 10%
Piotroski F5/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 26%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio13.9%
comfortable Shareholder yield0.9%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying2P / 2S insiders · 0 funds hold · 0 Congress buys
Recent insidersGrooms Nina C · DirectorBUY$39,985
Rizzuti Edward · EVP, Corp Dev, IR & SecretarySELL$102,555
Grooms Nina C · DirectorSELL$87,422
Hureau Robert Paul · President & CEOBUY$75,624
Bhealth · 71/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
- filingExecutive or board change 8-K filed 2026-07-08 · source →
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.